Table 2 ORR according to the line of treatment and the type of mCHT in elderly patients.

From: Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients

ORR

%

Overall (N = 111)

27.9

Ā 1st-line (N = 73)

35.2

Ā Ā VRL-based (N = 30)

46.7

Ā Ā CAPE-based (N = 20)

30.0

Ā Ā CTX-based (N = 18)

20.0

Ā Ā MTX-based (N = 5)

40.0

Ā 2nd-line (N = 29)

13.8

Ā Ā CAPE-based (N = 12)

41.4

Ā Ā VRL-based (N = 11)

37.9

Ā Ā CTX-based (N = 2)

Ā 

Ā 3rd-line (N = 5)

20.0

Ā 4th-line (N = 4)

25.0